Arca Biopharma reported $14K in Ordinary Share Capital for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Amgen AMGN:US $ 31343M 96M
Arca Biopharma ABIO:US $ 0.01M 0M
Biogen BIIB:US $ 0.1M 0M
Brainstorm Cell Therapeutics BCLI:US $ 0.01M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Capricor Therapeutics CAPR:US $ 0.02M 0M
Cytokinetics CYTK:US $ 0.08M 0M
Cytrx CYTR:US 43.48K 4.7K
Daiichi Sankyo 4568:JP Y 50000M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Laboratory Of America LH:US $ 8.3M 0.2M
Otsuka Holdings 4578:JP Y 81690M 0M
United Therapeutics UTHR:US $ 0.7M 0M